TY  - GEN
AU  - Bowles,D W
AU  - Kessler,E R
AU  - Jimeno,A
TI  - Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib)
SN  - 1699-3993
PY  - 2012///0306
KW  - Anilides
KW  - adverse effects
KW  - Animals
KW  - Antineoplastic Agents
KW  - Clinical Trials as Topic
KW  - Drug Interactions
KW  - Drugs, Investigational
KW  - Humans
KW  - Neoplasms
KW  - drug therapy
KW  - Proto-Oncogene Mas
KW  - Pyridines
KW  - Receptor Protein-Tyrosine Kinases
KW  - antagonists & inhibitors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1358/dot.2011.47.11.1688487
ER  -